Use of traditional Chinese medicine in preparing medicine for treating retinal vein obstruction
A technology of retinal veins and compositions, which is applied in the direction of drug combinations, active ingredients of hydroxyl compounds, and medical raw materials derived from arthropods, etc. The effect of blood viscosity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] a) The raw material drug formula is:
[0050] Ginseng 39.6g Leech 72.6g Wood Beetle 46.2g Frankincense (made) 13.2g
[0051] Paeoniae Rubra 33g Dalbergia 13.2g Sandalwood 13.2g Scorpio 19.8g
[0052] Cicada slough 46.2g centipede 6.6g borneol 33g Suanzaoren (stir-fried) 33g;
[0053] b) Crushing process of medicinal materials:
[0054] The scorpion, leech, centipede, ground beetle, and cicada slough five kinds of insect medicines have been cleaned, washed and processed, and the frankincense prepared after cleaning is prepared according to the prescription, and crushed by a pulverizer, and the fineness of the powder reaches more than 80 mesh; The powdered medicine is ultrafinely pulverized by various ultrafine pulverization techniques, so that the average particle size of the medicine powder is less than 30-40 μm; the medicinal materials to be pulverized are washed, dried and sterilized, and the ingredients are prepared;
[0055] c) Extraction concentration and drying...
experiment example
[0062] 1 Materials and methods
[0063] 1.1 General information
[0064] 52 routines (72 eyes) are clinically diagnosed as RVO patients and are completely randomly divided into two groups, the drug group of the present invention (observation group), 27 examples of 37 eyes, 14 males (20 eyes), 13 females (17 eyes); There were 7 cases (10 eyes) of central vein obstruction, including 2 cases of ischemic type and 5 cases of non-ischemic type; 20 cases (27 eyes) of branch vein obstruction, including 6 cases of ischemic type and 14 cases of non-ischemic type; age 23 to 68 years old, with an average age of 55.5±9.7 years; the course of disease ranged from 3 to 90 days, with an average of 31.9±23.8 days. Danshen injection group (control group) (manufactured by Shijiazhuang Shineway Pharmaceutical Co., Ltd.) 25 cases (35 eyes), 13 males (19 eyes), 12 females (16 eyes), including 8 cases (9 eyes) of retinal vein central trunk obstruction , including 3 cases of ischemic type and 6 case...
PUM
Property | Measurement | Unit |
---|---|---|
particle size | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com